Molecular genetics of head and neck cancer (Review)

Area of Science:

• Oncology
• Molecular Biology
• Cancer Therapeutics

Background:

• Head and neck cancer (HNC) treatment traditionally relies on surgery, radiation, and chemotherapy.
• Molecular regulatory pathways are increasingly recognized as crucial in HNC development and progression.
• Targeted therapies offer a more precise approach by interfering with specific molecular mechanisms driving cancer growth.

Purpose of the Study:

• To review major molecular signaling pathways implicated in the pathophysiology of head and neck cancer.
• To highlight the potential of targeting these pathways for novel therapeutic strategies.
• To discuss current clinical trials investigating targeted therapies in HNC based on in vitro findings.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of major signaling pathways in head and neck cancer.
• Summary of ongoing clinical trials for targeted therapies in HNC.

Main Results:

• Several key signaling pathways, including [specific pathways if known, e.g., EGFR, PI3K/AKT, MAPK], are critically involved in HNC.
• In vitro studies demonstrate significant efficacy of targeting these pathways.
• Numerous clinical trials are underway to evaluate these targeted therapies in HNC patients.

Conclusions:

• Targeting molecular regulatory pathways represents a promising therapeutic avenue for head and neck cancer.
• Further clinical investigation is warranted to translate in vitro successes into effective patient treatments.
• Personalized medicine approaches based on molecular profiling may enhance treatment outcomes in HNC.